Evidence map›Paper›PMID 34033169›Full record

ArticleAddiction (Abingdon, England)2021

Can novel 'swift-certain-fair' programs work outside of pioneering jurisdictions? An analysis of 24/7 Sobriety in Montana, USA.

Greg Midgette, Beau Kilmer

Abstract read
In one paragraph

Article in Addiction (Abingdon, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Greg MidgetteUniversity of Maryland, College Park, MD, USA.ORCID 0000-0003-2038-2950
Beau KilmerRAND, Santa Monica, CA, USA.ORCID 0000-0002-9333-8080

Funding

CAN SOUTH DAKOTA'S INNOVATIVE 24/7 SOBRIETY PROJECT WORK OUTSIDE SOUTH DAKOTAR21AA022439 · NIAAA · RAND CORPORATION · PI KILMER, BEAU GRIFFIN · 2014 to 2015
$454k
NIAAA NIH HHS R21 AA022439
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe US state of South Dakota's 24/7 Sobriety Program (24/7) requires individuals charged or convicted of alcohol-involved offenses to avoid alcohol and submit to twice-daily or continuous alcohol testing. We evaluated the impact of the 24/7 program in the US state of Montana.

methodsUsing data from everyone in Montana who was convicted of their second driving under the influence (DUI) offense from 2009 to August 2013, we described program violations among 24/7 participants and then estimated the effect of 24/7 participation on the probability of DUI re-arrest. To address potential selection issues related to individual-level 24/7 participation, we used an instrumental variables approach that exploits county-level variation in program adoption.

resultsAmong 2768 people convicted of a second DUI in our analytical sample, 356 participated in 24/7 and were monitored for an average of 173 days (median = 112 days). Among the 332 participants monitored by breath test, 95.5% of scheduled alcohol breath tests were completed and did not lead to a program violation. After controlling for individual- and community-level covariates as well as year and county fixed effects, our instrumental variable models suggested that participation in 24/7 reduced the 1-year DUI re-arrest probability by at least 80% (preferred model: 86% decrease; 8.9 percentage points) compared with a counterfactual group of people convicted of a second DUI over the same period but not assigned to the program.

conclusionsSouth Dakota USA's 24/7 Sobriety Program appears to work in Montana as well. Certain delivery of immediate but modest sanctions for repeat driving under the influence (DUI) arrestees who violate alcohol abstinence orders appears to be able to reduce future DUI arrests.

Indexed as

Automobile DrivingDriving Under the InfluenceAlcohol AbstinenceAlcohol DrinkingEthanolHumansLaw EnforcementMontanaEthanolAlcoholalcohol monitoringcommunity supervisioncriminal justiceprogram evaluationsobriety

Identifiers

PMID34033169
PMCPMC8578177

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.